Teva invests $30 million in US biotech co Wave Life Sciences - (Globes via NewsPoints Desk)

  • Teva has invested $30 million in Wave Life Sciences, giving the Israeli drugmaker a 9-percent stake in the US biotech firm, Globes reported Monday.
  • Wave Life Sciences noted that Teva expressed intentions to purchase a stake in the company following its initial public offering.
  • Separately, CTI Biopharma disclosed that it receive a payment of $10 million after meeting a milestone in the development of Trisenox.
  • Teva acquired rights to Trisenox in its purchase of Cephalon, which previously agreed to co-develop the therapy.

To read more NewsPoints articles, click here.